Kopran

Kopran Limited, founded in 1958 and trading under the ticker NSE: KOPRAN, is a prominent manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and Formulations. The company has established a significant global presence, exporting high-quality pharmaceutical products to over 60 countries worldwide. Kopran is committed to delivering affordable medicines while upholding the highest standards of quality and manufacturing practices, driven by its integrated pharmaceutical approach. Its operations are geared towards sustainable growth and enhancing competitiveness in the international healthcare market.

The company leverages state-of-the-art research and development capabilities to foster innovation and maintain its market position. With an experienced team of professionals, Kopran ensures robust product development and operational efficiency. Meet Kopran's team to gain insight into the expertise driving their pharmaceutical advancements. Kopran employs between 500 - 1,000 individuals, reflecting a substantial workforce dedicated to its mission of providing quality healthcare solutions. The company's focus on B2B operations and its presence in the Asia Pacific region highlight its strategic market engagement.

Kopran's product portfolio encompasses a diverse range of pharmaceutical ingredients and integrated formulations, catering to various therapeutic needs. The company's dedication to quality and its extensive international reach solidify its reputation as a reliable entity in the pharmaceutical industry. Its operational scale and commitment to excellence are key factors in its sustained presence and growth within the global pharmaceutical landscape.